Difference between revisions of "Pyoderma gangrenosum"
Jump to navigation
Jump to search
(split out) |
|||
| Line 2: | Line 2: | ||
==General== | ==General== | ||
*May be seen in [[IBD]] ( | *May be seen in [[IBD]] ([[ulcerative colitis]] and [[Crohn's disease]]) - approximately 30% of cases.<ref name=pmid16858047/> | ||
Clinical | Clinical | ||
| Line 48: | Line 48: | ||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||
[[Category: | [[Category:Dermatopathology]] | ||
Revision as of 20:14, 19 October 2015
Pyoderma gangrenosum is a benign inflammatory skin disorder associated with [[inflammatory
General
- May be seen in IBD (ulcerative colitis and Crohn's disease) - approximately 30% of cases.[1]
Clinical
Gross
- Skin ulceration - classically on the legs.[1]
Microscopic
Features:[1]
- Early: lymphocytes cells only in the dermis - often perivascular & vascular.
- +/-Fibrinoid necrosis of vessels at edge of lesion.
- Late: abscess formation (neutrophils).
DDx:
Image
Sign out
A. Skin, Left Leg from Central Wound, Punch Biopsy: - Necrotic debris with underlying granulation tissue and benign connective tissue with superficial vasculitis, see comment. - NEGATIVE for skin surface. B. Skin, Left Leg from Wound and Normal Skin Junction, Punch Biopsy: - Skin with ulceration, necrotic debris, and superficial vasculitis, see comment. - Fat necrosis and severe atherosclerosis. Comment: The findings are in keeping with pyoderma gangrenosum; however, atherosclerotic disease and vasculitis should be considered clinically. The vasculitis is seen superficially and is likely secondary to the ulceration.
See also
References
- ↑ 1.0 1.1 1.2 Brooklyn, T.; Dunnill, G.; Probert, C. (Jul 2006). "Diagnosis and treatment of pyoderma gangrenosum.". BMJ 333 (7560): 181-4. doi:10.1136/bmj.333.7560.181. PMC 1513476. PMID 16858047. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513476/.
- ↑ Wong, WW.; Machado, GR.; Hill, ME.. "Pyoderma gangrenosum: the great pretender and a challenging diagnosis.". J Cutan Med Surg 15 (6): 322-8. PMID 22202507.